Events & Presentations

Investors

Events & Presentations

Upcoming Events
Date Event Details Remind Me
Oct 18, 2019 8:00 AM EDT
Arrowhead Analyst R&D Day 2019
New York, NY
Archived Events
Date Event Details
Mar 26, 2019 4:35 PM EDT
Oligonucleotide & Precision Therapeutics (OPT) Congress
Cambridge, MA
James Hamilton, M.D., Arrowhead’s vice president of clinical development, will deliver an oral presentation titled, “siRNA Clinical Development Based on the TRiMTM Platform”
Mar 18, 2019 9:30 AM EDT
Jefferies HBV Investor Summit
New York
Dr. Given will participate in a fireside chat presentation with Maury Raycroft, Ph.D., Jefferies Biotech Analyst
Mar 12, 2019 4:20 PM EDT
Barclays Global Healthcare Conference 2019
Miami
Bruce Given, M.D., Arrowhead’s chief operating officer, will deliver a corporate presentation.
Feb 22, 2019
APASL 2019
Dr. Edward Gane will deliver a poster presentation titled, “RNA interference (RNAi) in chronic hepatitis B (CHB): Data from Phase 2 study with JNJ-3989”
Feb 7, 2019 4:30 PM EST
Arrowhead Pharmaceuticals 2019 First Quarter Results
Dec 11, 2018 4:30 PM EST
Arrowhead 2018 Fiscal Year End Results
Nov 28, 2018
30th Annual Piper Jaffray Healthcare Conference
New York, NY
November 28, 3:30 p.m. EST – Dr. Anzalone will participate in a fireside chat
Nov 16, 2018
China Nucleic Acids
Guangzhou, China
November 16, 11:20 – Dr. Li will deliver an oral presentation titled, “TRiMTM Platform Based RNAi Therapeutics for AATD and Cardiometabolic Diseases”
Nov 15, 2018
Jefferies 2018 London Healthcare
London
November 15, 2:00 p.m. GMT – Christopher Anzalone, Ph.D., Arrowhead’s president and chief executive officer, will deliver a corporate presentation
Nov 13, 2018
30th EORTC-NCI-AACR Symposium
Dublin
November 13, 10:00 a.m. GMT – Dr. Given will deliver a poster presentation titled, “Targeting HIF2α with an RNAi therapeutic for the treatment of clear cell renal cell carcinoma”